Home › Metastatic Cancer › California › Orange
Pag-aaral pangklinika para sa Metastatic Cancer sa Orange, CA
Isang pag-aaral para sa Metastatic Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Orange. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Nagre-recruitPhase 2
- Children's Hospital of Orange County, Orange
- Saint Joseph Hospital - Orange, Orange
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
Nagre-recruitPhase 1
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
Nagre-recruitPhase 1/2
- University of California Irvine, Orange
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
Nagre-recruitPhase 1
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Nagre-recruitPhase 2
- UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Nagre-recruitPhase 2/3
- UC Irvine Health, Orange
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
Nagre-recruitPhase 1/2
- UCI Medical Center, Orange
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Nagre-recruitPhase 3
- University of California, Irvine (UCI) Health - UC Irvine Medical Center, Orange
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Nagre-recruitPhase 3
- University of California, Irvine (UCI) Health - UC Irvine Medical Center, Orange
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Nagre-recruitPhase 1/2
- UC IRVINE Health, Orange
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
Nagre-recruitPhase 1/2
- University of California-Irvine Medical Center ( Site 0016), Orange
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Nagre-recruitPhase 1
- University of California - Irvine, Orange
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
Nagre-recruitPhase 1/2
- Crinetics Study Site, Orange
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
Nagre-recruitPhase 1/2
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Nagre-recruitPhase 3
- Research Site, Orange
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1
- Research Site, Orange
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Nagre-recruitPhase 1/2
- University of California Irvine Medical Center, Orange
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Nagre-recruitPhase 1/2
- UC Irvine/Chao Family Comprehensive Cancer Center, Orange
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1
- Stern Center for Cancer Clinical Trials and Research, Orange
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Orange
Pag-aaral para sa Metastatic Cancer sa ibang lungsod
- Houston, TX104 pag-aaral
- New York City, NY93 pag-aaral
- Nashville, TN70 pag-aaral
- Boston, MA63 pag-aaral
- Los Angeles, CA57 pag-aaral
- St. Louis, MO54 pag-aaral
- Arlington, VA53 pag-aaral
- Philadelphia, PA46 pag-aaral
- Chicago, IL45 pag-aaral
- San Antonio, TX44 pag-aaral
- Washington, DC43 pag-aaral
- Dallas, TX42 pag-aaral
Iba pang pag-aaral sa Orange
- Non-Small Cell Lung Cancer25 pag-aaral
- Colorectal Cancer16 pag-aaral
- Kanser sa Ovary16 pag-aaral
- Kanser sa Pancreas15 pag-aaral
- Melanoma14 pag-aaral
- Kanser sa Atay (Hepatocellular Carcinoma)14 pag-aaral
- Kanser sa Suso14 pag-aaral
- Kanser sa Baga14 pag-aaral
- Kanser sa Prostate14 pag-aaral
- Kanser sa Tiyan13 pag-aaral
- Kanser (lahat ng uri)13 pag-aaral
- Acute Myeloid Leukemia13 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.